Immunization in Canada: a success to build onHALPERIN, Scott A; PLESS, Robert.Journal of the Canadian Chiropractic Association. 2003, Vol 47, Num 3, pp 153-160, issn 0008-3194, 8 p.Article

Overcoming codon-usage bias in heterologous protein expression in Streptococcus gordoniiLEE, Song F; LI, Yi-Jing; HALPERIN, Scott A et al.Microbiology (Reading). 2009, Vol 155, pp 3581-3588, issn 1350-0872, 8 p., 11Article

Regulation of D-alanylation of lipoteichoic acid in Streptococcus gordoniiMCCORMICK, Nicole E; HALPERIN, Scott A; LEE, Song F et al.Microbiology (Reading). 2011, Vol 157, pp 2248-2256, issn 1350-0872, 9 p., 8Article

Cellular Immunity as a Potential Cause of Local Reactions to Booster Vaccination With Diphtheria and Tetanus Toxoids and Acellular Pertussis AntigensSCHEIFELE, David W; OCHNIO, Jan J; HALPERIN, Scott A et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 11, pp 985-989, issn 0891-3668, 5 p.Article

Expression and immunogenicity of a recombinant diphtheria toxin fragment A in Streptococcus gordoniiLEE, Chiang W; LEE, Song F; HALPERIN, Scott A et al.Applied and environmental microbiology (Print). 2004, Vol 70, Num 8, pp 4569-4574, issn 0099-2240, 6 p.Article

Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigensSCHEIFELE, David W; HALPERIN, Scott A; FERGUSON, Alexander C et al.Vaccine. 2001, Vol 19, Num 32, pp 4720-4726, issn 0264-410XArticle

Lack of evidence of encephalopathy related to pertussis vaccine: Active Surveillance by IMPACT, Canada, 1993-2002MOORE, Dorothy L; LE SAUX, Nicole; SCHEIFELE, David et al.The Pediatric infectious disease journal. 2004, Vol 23, Num 6, pp 568-571, issn 0891-3668, 4 p.Article

Purification and immunogenicity of a recombinant Bordetella pertussis S1S3FHA fusion protein expressed by Streptococcus gordoniiLEE, Song F; HALPERIN, Scott A; KNIGHT, Jennifer B et al.Applied and environmental microbiology (Print). 2002, Vol 68, Num 9, pp 4253-4258, issn 0099-2240, 6 p.Article

Toward more specific and transparent research and development costs: The case of seasonal influenza vaccinesCHIT, Ayman; PARKER, Jayson; HALPERIN, Scott A et al.Vaccine. 2014, Vol 32, Num 26, pp 3336-3340, issn 0264-410X, 5 p.Article

Role of surface proteins SspA and SspB of Streptococcus gordonii in innate immunityANDRIAN, Elisoa; GAOFU QI; JUN WANG et al.Microbiology (Reading). 2012, Vol 158, pp 2099-2106, issn 1350-0872, 8 p., 8Article

Outbreak of Atypical Pertussis Detected by Polymerase Chain Reaction in Immunized Preschool-Aged ChildrenWATERS, Valerie; JAMIESON, Frances; RICHARDSON, Susan E et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 7, pp 582-587, issn 0891-3668, 6 p.Article

The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in CanadaBETTINGER, Julie A; HALPERIN, Scott A; DE SERRES, Gaston et al.The Pediatric infectious disease journal. 2007, Vol 26, Num 1, pp 31-35, issn 0891-3668, 5 p.Article

Use of lidocaine-prilocaine patch to decrease intramuscular injection pain does not adversely affect the antibody response to diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate and hepatitis B vaccines in infants from birth to six months of ageHALPERIN, Beth A; HALPERIN, Scott A; MCGRATH, Patrick et al.The Pediatric infectious disease journal. 2002, Vol 21, Num 5, pp 399-405, issn 0891-3668Article

Pertussis immunization in paediatric healthcare workers: Knowledge, attitudes, beliefs, and behaviourTOP, Karina A; HALPERIN, Beth A; BAXENDALE, Darlene et al.Vaccine. 2010, Vol 28, Num 10, pp 2169-2173, issn 0264-410X, 5 p.Article

Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric proteinLEE, Song F; HALPERIN, Scott A; SALLOUM, Danny F et al.Infection and immunity. 2003, Vol 71, Num 4, pp 2272-2275, issn 0019-9567, 4 p.Article

Safety and Immunogenicity of a Toddler Dose Following an Infant Series of a Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b, Hepatitis B Vaccine Administered Concurrently or at Separate Visits With a Heptavalent Pneumococcal Conjugate VaccineHALPERIN, Scott A; TAPIERO, Bruce; MINRAN LI et al.The Pediatric infectious disease journal. 2014, Vol 33, Num 1, pp 73-80, issn 0891-3668, 8 p.Article

The Hidden Costs and Characteristics of Childhood Rotavirus Emergency Visits in CanadaLE SAUX, Nicole; BETTINGER, Julie; DERY, Pierre et al.The Pediatric infectious disease journal. 2012, Vol 31, Num 2, pp 159-163, issn 0891-3668, 5 p.Article

SUBSTANTIAL MORBIDITY FOR HOSPITALIZED CHILDREN WITH COMMUNITY-ACQUIRED ROTAVIRUS INFECTIONS: 2005-2007 IMPACT SURVEILLANCE IN CANADIAN HOSPITALSLE SAUX, Nicole; BETTINGER, Julie A; HALPERIN, Scott A et al.The Pediatric infectious disease journal. 2010, Vol 29, Num 9, pp 879-882, issn 0891-3668, 4 p.Article

The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000―2007BETTINGER, Julie A; SCHEIFELE, David W; KELLNER, James D et al.Vaccine. 2010, Vol 28, Num 9, pp 2130-2136, issn 0264-410X, 7 p.Article

Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of ageHALPERIN, Scott A; GUPTA, Anil; JEANFREAU, Robert et al.Vaccine. 2010, Vol 28, Num 50, pp 7865-7872, issn 0264-410X, 8 p.Article

A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunityKINDRACHUK, Jason; JENSSEN, Havard; ELLIOTT, Melissa et al.Vaccine. 2009, Vol 27, Num 34, pp 4662-4671, issn 0264-410X, 10 p.Article

Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of ageHALPERIN, Scott A; FERRERA, Giuseppe; SCHEIFELE, David et al.Vaccine. 2009, Vol 27, Num 20, pp 2701-2706, issn 0264-410X, 6 p.Article

Comparison of the safety and immunogenicity of hepatitis b virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adultsHALPERIN, Scott A; DOBSON, Simon; MCNEIL, Shelly et al.Vaccine. 2006, Vol 24, Num 1, pp 20-26, issn 0264-410X, 7 p.Article

Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccineHALPERIN, Scott A; SCHEIFELE, David; MILLS, Elaine et al.Vaccine. 2003, Vol 21, Num 19-20, pp 2298-2306, issn 0264-410X, 9 p.Article

Predictors of death in infants hospitalized with pertussis : A case-control study of 16 pertussis deaths in CanadaMIKELOVA, Lynda K; HALPERIN, Scott A; SCHEIFELE, David et al.The Journal of pediatrics. 2003, Vol 143, Num 5, pp 576-581, issn 0022-3476, 6 p.Article